Showing 1 - 20 results of 106 for search 'Alzheimer’s disease biomarkers', query time: 0.08s Refine Results
  1. 1
  2. 2
  3. 3

    Perspectives in Molecular Imaging Using Staging Biomarkers and Immunotherapies in Alzheimer’s Disease by Benoît Leclerc, Abedelnasser Abulrob

    Published 2013-01-01
    “…Sporadic Alzheimer’s disease (AD) is an emerging chronic illness characterized by a progressive pleiotropic pathophysiological mode of actions triggered during the senescence process and affecting the elderly worldwide. …”
    Get full text
    Article
  4. 4

    PROTEOMIC PROFILING OF BLOOD-BASED BIOMARKERS IN THE EARLY DETECTION OF ALZHEIMERS DISEASE by Syeda Uroosa Hashmi, Fahad Farooq Lasi

    Published 2024-06-01
    “…The monomeric forms of Aβ aggregate to form fibrils and a variety of oligomers which later become neurotoxic. Alzheimer's disease is considered an incurable, irreversible, and progressive type of neurodegenerative disease, in which the symptoms of dementia become worse with time. …”
    Get full text
    Article
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    Mitochondrial- and Endoplasmic Reticulum-Associated Oxidative Stress in Alzheimer's Disease: From Pathogenesis to Biomarkers by E. Ferreiro, I. Baldeiras, I. L. Ferreira, R. O. Costa, A. C. Rego, C. F. Pereira, C. R. Oliveira

    Published 2012-01-01
    “…Alzheimer's disease (AD) is the most common cause of dementia in the elderly, affecting several million of people worldwide. …”
    Get full text
    Article
  10. 10
  11. 11
  12. 12
  13. 13

    β-synuclein in cerebrospinal fluid as a potential biomarker for distinguishing human prion diseases from Alzheimer’s and Parkinson’s disease by Bing Xu, Kang Xiao, Xiaoxi Jia, Rundong Cao, Donglin Liang, Ruhan A, Weiwei Zhang, Chunjie Li, Liping Gao, Cao Chen, Qi Shi, Xiaoping Dong

    Published 2025-02-01
    “…Abstract Background β-synuclein (β-syn), mainly expressed in central nerve system, is one of the biomarkers in cerebrospinal fluid (CSF) and blood for synaptic damage, which has been reported to be elevated in CSF and blood of the patients of prion diseases (PrDs). …”
    Get full text
    Article
  14. 14
  15. 15
  16. 16

    Association between herpes simplex virus infection and Alzheimer’s disease biomarkers: analysis within the MAPT trial by Morgane Linard, Isabelle Garrigue, Bruno Vellas, Nicola Coley, Henrik Zetterberg, Kaj Blennow, Nicholas James Ashton, Pierre Payoux, Anne-Sophie Salabert, Jean-François Dartigues, Joachim Mazere, Sandrine Andrieu, Catherine Helmer

    Published 2025-01-01
    “…Here, we studied the association between HSV-1 and Alzheimer’s disease biomarkers in humans. Our sample included 182 participants at risk of cognitive decline from the Multidomain Alzheimer Preventive Trial who had HSV-1 plasma serology and an amyloid PET scan. …”
    Get full text
    Article
  17. 17
  18. 18

    Multimodal MRI Neuroimaging Biomarkers for Cognitive Normal Adults, Amnestic Mild Cognitive Impairment, and Alzheimer's Disease by Ai-Ling Lin, Angela R. Laird, Peter T. Fox, Jia-Hong Gao

    Published 2012-01-01
    “…This paper discusses recent findings of the multimodal MRI in the context of surrogate biomarkers for identifying the risk for AD in normal cognitive (NC) adults, brain anatomical and functional alterations in amnestic mild cognitive impairment (aMCI), and Alzheimer's disease (AD) patients. …”
    Get full text
    Article
  19. 19

    Exploring the Kidney-Brain Crosstalk: Biomarkers for Early Detection of Kidney Injury-Related Alzheimer’s Disease by Cai Y, Huang G, Ren M, Chai Y, Fu Y, Yan T, Zhu L

    Published 2025-01-01
    “…Keywords: kidney injury, Alzheimer’s disease, kidney-brain crosstalk, ferroptosis, bioinformatics, machine learning…”
    Get full text
    Article
  20. 20